These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine]. Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142 [TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of annual booster inoculations against various influenza serotypes and the procedure for mass vaccination]. Slepushkin AN; Schastnyĭ EI; Obrosova-Serova NP; Kobzeva OB; Tomas LP Vopr Virusol; 1987; 32(6):656-60. PubMed ID: 3445582 [TBL] [Abstract][Full Text] [Related]
5. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method]. Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581 [No Abstract] [Full Text] [Related]
13. Influenza A (H3N2) component of recommended vaccine induces antibody to current virus. Zuckerman M; Oxford J; Wood J; Taylor J Lancet; 1990 Jan; 335(8682):179-80. PubMed ID: 1967480 [No Abstract] [Full Text] [Related]
14. [The immunological shifts in the blood sera of persons inoculated with influenza vaccines]. Stepanovskaia LD; Solomko RM; Avratinskiĭ IM; Katuntsevskaia GP; Kiriliuk ZhI; Iampol'skiĭ MP; Burdeniuk EI Mikrobiol Zh (1978); 1992; 54(4):70-5. PubMed ID: 1406385 [TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Burtseva EI; Obrosova-Serova NP; Govorkova EA; Rudenko LG; Vartanian RV; Beliaev AL; Ivanova VT; Musina MD; Cheshek SG; Zazimko LA Vopr Virusol; 1991; 36(5):375-7. PubMed ID: 1803767 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325 [TBL] [Abstract][Full Text] [Related]
17. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. World Health Organization Wkly Epidemiol Rec; 2005 Feb; 80(8):71-5. PubMed ID: 15771207 [No Abstract] [Full Text] [Related]
18. Vaccines against avian influenza--a race against time. Poland GA N Engl J Med; 2006 Mar; 354(13):1411-3. PubMed ID: 16571885 [No Abstract] [Full Text] [Related]
19. [Postvaccinal anti-influenza immunity and its determining factors]. Kastrikina LN; Lonskaia NI Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774 [No Abstract] [Full Text] [Related]
20. The use of inactivated influenza vaccine in children. Wright PF Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]